News Xcelerate Inc.

Equities

XCRT

US98401T1051

Delayed OTC Markets Other stock markets 02:54:34 2024-04-18 pm EDT			5-day change	1st Jan Change
0.0373 ^USD	+1.47%		+13.37%	+3.61%

2023	Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	CI
2023	Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence	Mar. 26	AQ
Xcelerate, Inc. Announces Participation in The Microcap Conference	Jan. 19	NE
Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	Nov. 13	CI
Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	23-10-24	CI
Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-22	CI
Xcelerate Announces Marketing Agreement with ProductSector, LLC	23-08-08	CI
Xcelerate, Inc. Acquires a Majority Interest in ESN Group	23-07-26	AQ
Xcelerate Inc. acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.	23-07-23	CI
Xcelerate Inc. completed the acquisition of an unknown majority stake in ESN Group, Inc.	23-07-19	CI
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	23-04-27	CI
Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board	23-02-01	CI
Xcelerate Inc. entered into a letter of intent to acquire an unknown majority stake in ESN Group, Inc.	23-01-16	CI
Tenet Announces Partnership with Xcelerate Auto to Offer New Warranty Options	22-09-28	AQ
Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-15	CI
Xcelerate : Announces Uplisting to OTCQB Market	22-08-01	PU
Xcelerate : OTCQB Certification	22-07-19	PU
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT	22-05-23	AQ
Michael O’Shea CEO, Releases Shareholder Update	22-03-09	AQ
Fran White to Join the Advisory Board of Xcelerate, Inc.	22-02-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xcelerate Inc.

Equities

XCRT

US98401T1051

Summary

Filters